Why your heart still risks failure even if your cholesterol is low
Role of Residual Inflammation as a Risk Factor Across Cardiovascular-Kidney-Metabolic (CKM) Syndrome: Unpacking the Burden in People with Type 2 Diabetes
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Even when diabetes patients take pills to lower sugar and cholesterol, their heart and kidneys can still get damaged because of hidden body inflammation. New medicines that calm this inflammation can stop more heart attacks and kidney failures.
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 51 / 5
Evidence Score
Based on clinical experience or non-systematic literature reviews. The lowest level of evidence as they are most susceptible to bias and personal perspective.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Even when diabetes patients take pills to lower sugar and cholesterol, their heart and kidneys can still get damaged because of hidden body inflammation. New medicines that calm this inflammation can stop more heart attacks and kidney failures.
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Systematic Reviews & Meta-Analyses
Max 100Randomized Controlled Trials
Max 90Cohort Studies
Max 72Case-Control Studies
Max 58Cross-Sectional Studies
Max 44Case Reports & Case Series
Max 30Expert Opinion & Narrative Reviews
Max 51 / 5
Evidence Score
Based on clinical experience or non-systematic literature reviews. The lowest level of evidence as they are most susceptible to bias and personal perspective.
Publication
Authors
Ghafoury R, Malek M, Ismail-Beigi F, Khamseh ME
Related Content
Claims (5)
Cardiovascular risk persists despite low LDL cholesterol levels if concomitant metabolic syndrome, hypertension, chronic inflammation, or dysglycemia remain unaddressed.
Even when diabetics take pills to lower their bad cholesterol, if they still have high levels of a blood marker called hsCRP, they’re still at high risk for heart attacks and strokes — meaning inflammation is still hurting them.
A class of diabetes drugs (SGLT2 inhibitors) cuts hospitalizations for heart failure by a third and lowers death risk by nearly 40% — even before blood sugar improves — suggesting they protect the heart in ways beyond lowering sugar.
Diabetes drugs like semaglutide and liraglutide cut heart attacks, strokes, and kidney failure by up to a third — and they work fast, even before blood sugar drops, likely by calming down harmful inflammation in the body.
High blood sugar in diabetes turns on harmful inflammation pathways in the body — damaging blood vessels, kidneys, and the heart — by creating toxic molecules and activating immune switches like NF-κB and NLRP3.